NDUFA10 Antibody - #DF2211
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# DF2211, RRID:AB_2839442.
折りたたみ/展開
CI 42KD; CI-42k; Complex I-42kD; MGC5103; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 10; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 10 42kDa; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial complex I 42kDa subunit; NADH ubiquinone oxidoreductase 42 kDa subunit mitochondrial precursor; NADH-ubiquinone oxidoreductase 42 kDa subunit; ndufa10l;
免疫原
- O95299 NDUAA_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MALRLLKLAATSASARVVAAGAQRVRGIHSSVQCKLRYGMWHFLLGDKASKRLTERSRVITVDGNICTGKGKLAKEIAEKLGFKHFPEAGIHYPDSTTGDGKPLATDYNGNCSLEKFYDDPRSNDGNSYRLQSWLYSSRLLQYSDALEHLLTTGQGVVLERSIFSDFVFLEAMYNQGFIRKQCVDHYNEVKSVTICDYLPPHLVIYIDVPVPEVQRRIQKKGDPHEMKITSAYLQDIENAYKKTFLPEMSEKCEVLQYSAREAQDSKKVVEDIEYLKFDKGPWLKQDNRTLYHLRLLVQDKFEVLNYTSIPIFLPEVTIGAHQTDRVLHQFRELPGRKYSPGYNTEVGDKWIWLK
種類予測
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - O95299 基板として
Site | PTM Type | Enzyme | Source |
---|---|---|---|
K48 | Ubiquitination | Uniprot | |
S57 | Phosphorylation | Uniprot | |
T61 | Phosphorylation | Uniprot | |
K80 | Acetylation | Uniprot | |
K80 | Ubiquitination | Uniprot | |
K84 | Ubiquitination | Uniprot | |
K102 | Ubiquitination | Uniprot | |
K181 | Ubiquitination | Uniprot | |
K221 | Acetylation | Uniprot | |
T230 | Phosphorylation | Uniprot | |
S231 | Phosphorylation | Uniprot | |
Y233 | Phosphorylation | Uniprot | |
Y241 | Phosphorylation | Uniprot | |
K242 | Acetylation | Uniprot | |
K242 | Ubiquitination | Uniprot | |
K243 | Acetylation | Uniprot | |
K243 | Ubiquitination | Uniprot | |
S250 | Phosphorylation | Uniprot | |
K252 | Ubiquitination | Uniprot | |
K267 | Acetylation | Uniprot | |
K268 | Ubiquitination | Uniprot | |
Y275 | Phosphorylation | Uniprot | |
K277 | Ubiquitination | Uniprot | |
K280 | Ubiquitination | Uniprot | |
K285 | Ubiquitination | Uniprot | |
K338 | Ubiquitination | Uniprot | |
T345 | Phosphorylation | Uniprot | |
K350 | Ubiquitination | Uniprot |
研究背景
Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone.
Phosphorylation at Ser-250 by PINK1 is required for the binding and/or reduction of the complex I substrate ubiquinone.
Mitochondrion matrix.
Complex I is composed of 45 different subunits. This a component of the hydrophobic protein fraction.
Belongs to the complex I NDUFA10 subunit family.
研究領域
· Human Diseases > Endocrine and metabolic diseases > Non-alcoholic fatty liver disease (NAFLD).
· Human Diseases > Neurodegenerative diseases > Alzheimer's disease.
· Human Diseases > Neurodegenerative diseases > Parkinson's disease.
· Human Diseases > Neurodegenerative diseases > Huntington's disease.
· Metabolism > Energy metabolism > Oxidative phosphorylation.
· Metabolism > Global and overview maps > Metabolic pathways.
· Organismal Systems > Nervous system > Retrograde endocannabinoid signaling. (View pathway)
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.